[go: up one dir, main page]

GB0305793D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB0305793D0
GB0305793D0 GB0305793A GB0305793A GB0305793D0 GB 0305793 D0 GB0305793 D0 GB 0305793D0 GB 0305793 A GB0305793 A GB 0305793A GB 0305793 A GB0305793 A GB 0305793A GB 0305793 D0 GB0305793 D0 GB 0305793D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0305793A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GB0305793A priority Critical patent/GB0305793D0/en
Publication of GB0305793D0 publication Critical patent/GB0305793D0/en
Priority to PCT/EP2004/002642 priority patent/WO2004081045A2/en
Ceased legal-status Critical Current

Links

GB0305793A 2003-03-13 2003-03-13 Vaccine Ceased GB0305793D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0305793A GB0305793D0 (en) 2003-03-13 2003-03-13 Vaccine
PCT/EP2004/002642 WO2004081045A2 (en) 2003-03-13 2004-03-11 Vaccine related to modified apolipoprotein c-iii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0305793A GB0305793D0 (en) 2003-03-13 2003-03-13 Vaccine

Publications (1)

Publication Number Publication Date
GB0305793D0 true GB0305793D0 (en) 2003-04-16

Family

ID=9954732

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0305793A Ceased GB0305793D0 (en) 2003-03-13 2003-03-13 Vaccine

Country Status (2)

Country Link
GB (1) GB0305793D0 (en)
WO (1) WO2004081045A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23736A1 (en) 2009-05-04 2011-11-15 Centro Inmunologia Molecular ANTIBODIES RECOGNIZING SULFATIDES AND SULFATED PROTEOGLYCANS AND THEIR USE
CN106811443A (en) * 2015-11-27 2017-06-09 西藏自治区人民医院 The preparation and application of Apolipoprotein C-III monoclonal antibody
CA3030099A1 (en) 2016-07-08 2018-01-11 Staten Biotechnology B.V. Anti-apoc3 antibodies and methods of use thereof
WO2018193427A1 (en) 2017-04-21 2018-10-25 Staten Biotechnology B.V. Anti-apoc3 antibodies and methods of use thereof
PE20210119A1 (en) 2017-10-31 2021-01-19 Staten Biotechnology B V ANTI-APOC3 ANTIBODIES AND METHODS OF USE OF THEM
US10538583B2 (en) 2017-10-31 2020-01-21 Staten Biotechnology B.V. Anti-APOC3 antibodies and compositions thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2401755A1 (en) * 2000-03-03 2001-09-07 Smithkline Beecham Biologicals S.A. Vaccine for the treatment of artherosclerosis
GB0121171D0 (en) * 2001-08-31 2001-10-24 Glaxosmithkline Biolog Sa Vaccine
US6930085B2 (en) * 2002-04-05 2005-08-16 The Regents Of The University Of California G-type peptides to ameliorate atherosclerosis

Also Published As

Publication number Publication date
WO2004081045A2 (en) 2004-09-23
WO2004081045A3 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
GB0226722D0 (en) Vaccine
GB0329146D0 (en) Vaccine
IL173921A0 (en) Vaccine
GB0225788D0 (en) Vaccine
AU2003285320A8 (en) Vaccine
GB0323840D0 (en) Vaccines
GB0228715D0 (en) Vaccine
GB0209878D0 (en) Vaccine
GB0305794D0 (en) Vaccine
GB0330079D0 (en) Vaccine
PL376534A1 (en) Vaccine
GB0305793D0 (en) Vaccine
GB0321614D0 (en) Vaccines
GB0304634D0 (en) Vaccines
AU2003237701A8 (en) Vaccines
GB0206595D0 (en) Vaccine
IL156434A0 (en) Vaccine
GB0330007D0 (en) Vaccines
GB0223355D0 (en) Vaccine
GB0226179D0 (en) Vaccine
GB0329827D0 (en) Vaccine
GB0305028D0 (en) Vaccine
GB0327885D0 (en) Vaccine
GB0326757D0 (en) Vaccine
GB0304635D0 (en) Vaccines

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)